Treatment of Metastatic Colorectal Cancer: ASCO Guideline
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).
Van K. Morris
Consulting or Advisory Role: Incyte, Servier, Boehringer Ingelheim, Axiom Healthcare Strategies, BioMedical Insights, Bicara Therapeutics
Research Funding: Bristol Myers Squibb (Inst), EMD Serono (Inst), Immatics, Pfizer (Inst), BioNTech (Inst), Bicara Therapeutics (Inst)
Al B. Benson
Consulting or Advisory Role: Merck Sharp & Dohme, Array BioPharma, Bristol Myers Squibb, Samsung Bioepis, Pfizer, HalioDx, AbbVie, Janssen Oncology, Natera, Apexigen, Artemida Pharma, Xencor, Therabionic, Mirati Therapeutics, Boston Scientific, Hutchmed
Research Funding: Infinity Pharmaceuticals (Inst), Merck Sharp & Dohme (Inst), Taiho Pharmaceutical (Inst), Bristol Myers Squibb (Inst), Celgene (Inst), Rafael Pharmaceuticals (Inst), MedImmune (Inst), Xencor (Inst), Astellas Pharma (Inst), Amgen (Inst), SynCoreBio (Inst), Elevar Therapeutics (Inst), Tyme Inc (Inst), ST Pharm (Inst), ITM Solucin (Inst)
Andrea Cercek
Consulting or Advisory Role: Bayer, GlaxoSmithKline, Incyte, Merck, Janssen, Seattle Genetics
Research Funding: Seattle Genetics, Rgenix (Inst), GlaxoSmithKline
May Cho
Consulting or Advisory Role: Amgen, Eisai, Taiho Pharmaceutical, Astellas Pharma, Exelixis, Ipsen, Seattle Genetics, QED Therapeutics, AstraZeneca/MedImmune, Basilea, Genentech/Roche
Speakers' Bureau: Taiho Pharmaceutical, Pfizer, Natera, Bristol Myers Squibb/Celgene, Helsinn Therapeutics, Daiichi Sankyo/Astra Zeneca
Research Funding: Bristol Myers Squibb (Inst), Seattle Genetics (Inst), AstraZeneca/MedImmune (Inst), Incyte (Inst), Immunocore (Inst)
Travel, Accommodations, Expenses: AstraZeneca/MedImmune
Kristen K. Ciombor
Consulting or Advisory Role: Merck, Pfizer, Lilly, Seattle Genetics, Replimune, Personalis
Research Funding: Pfizer (Inst), Boston Biomedical (Inst), MedImmune (Inst), Onyx (Inst), Bayer (Inst), Boehringer Ingelheim (Inst), Bristol Myers Squibb (Inst), Merck (Inst), Novartis (Inst), Incyte (Inst), Amgen (Inst), Sanofi (Inst), Bristol Myers Squibb (Inst), Array BioPharma (Inst), Daiichi Sankyo (Inst), Nucana (Inst), AbbVie (Inst), Merck (Inst), Pfizer/Calithera (Inst), Genentech (Inst)
Travel, Accommodations, Expenses: Array BioPharma
Chiara Cremolini
Honoraria: Roche, Amgen, Bayer, Servier, MSD, Merck, Pierre Fabre, Organon
Consulting or Advisory Role: Roche, Bayer, Amgen, MSD, Pierre Fabre, Nordic Pharma
Speakers' Bureau: Servier, Merck, Pierre Fabre
Research Funding: Merck, Bayer, Roche, Servier
Anjee Davis
Honoraria: Daiichi Sankyo/UCB Japan (Inst), Komodo Health (Inst)
Travel, Accommodations, Expenses: Komodo Health (Inst)
Uncompensated Relationships: Taiho Oncology, Exact Sciences, Flatiron Health
Dustin A. Deming
Consulting or Advisory Role: Bayer, Promega, Array BioPharma, Lilly, Pfizer
Research Funding: Merck (Inst), Bristol Myers Squibb (Inst), Genentech (Inst), Revolution Medicines (Inst), Millennium (Inst), Bayer
Marwan G. Fakih
Honoraria: Amgen
Consulting or Advisory Role: Amgen, Taiho Pharmaceutical, Bayer, Pfizer, Seattle Genetics, GlaxoSmithKline, Incyte, Nouscom, Roche/Genentech, Mirati Therapeutics
Speakers' Bureau: Guardant Health
Research Funding: Amgen (Inst), Verastem (Inst)
Sepideh Gholami
Consulting or Advisory Role: Signatera, QED Therapeutics, TRUSELTIQ
Speakers' Bureau: Helsinn Therapeutics
Theodore S. Hong
Stock and Other Ownership Interests: PanTher Therapeutics
Consulting or Advisory Role: Merck, Synthetic Biologics, Novocure, Syndax, Boston Scientific
Research Funding: Taiho Pharmaceutical (Inst), AstraZeneca (Inst), IntraOp (Inst), Tesaro (Inst), Bristol Myers Squibb (Inst), Ipsen (Inst)
Kelsey Klute
Consulting or Advisory Role: Cancer Expert Now, Daiichi Sankyo/Lilly, Pfizer
Research Funding: AstraZeneca (Inst), FibroGen (Inst)
Christopher Lieu
Consulting or Advisory Role: Pfizer (Inst)
Research Funding: Merck (Inst)
Hanna Sanoff
Research Funding: AstraZeneca (Inst), Roche (Inst), Amgen (Inst), Bristol Myers Squibb (Inst), Pfizer (Inst), BioMed Valley Discoveries (Inst), Rgenix (Inst), Exelixis (Inst)
John H. Strickler
Consulting or Advisory Role: Bayer, Natera (Inst), Pfizer, Mereo Biopharma, AstraZeneca, Viatris, Seattle Genetics, Roche/Genentech (Inst), Inivata, Silverback Therapeutics, GlaxoSmithKline, Pionyr, AbbVie, Takeda, Zentalis
Research Funding: AbbVie (Inst), Roche/Genentech (Inst), Leap Therapeutics (Inst), Nektar (Inst), Amgen (Inst), Curegenix (Inst), A*STAR (Inst), Bayer (Inst), AstraZeneca/MedImmune (Inst), Sanofi (Inst), Daiichi Sankyo/Lilly, Silverback Therapeutics (Inst), Erasca Inc (Inst), Seattle Genetics (Inst)
Travel, Accommodations, Expenses: Guardant Health, Seattle Genetics
Sarah White
Honoraria: Varian Medical Systems
Consulting or Advisory Role: Cook Medical, Guerbet, AstraZeneca
Speakers' Bureau: Penumbra
Research Funding: Focused Ultrasound Foundation (Inst), Guerbet (Inst), InSightec (Inst)
Travel, Accommodations, Expenses: Cook Medical
Open Payments Link: https://openpaymentsdata.cms.gov/physician/167903
Jason A. Willis
Honoraria: Cor2Ed
Cathy Eng
Consulting or Advisory Role: GlaxoSmithKline, Bayer Health, Natera, Janssen Oncology, HalioDx
Research Funding: Fruquitinib (Inst), Elevar Therapeutics (Inst)
Uncompensated Relationships: Pfizer (Inst), Merck (Inst)
No other potential conflicts of interest were reported.
留言 (0)